Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Chinese Patent Office
Daiichi Sankyo
Covington
Cerilliant
QuintilesIMS
Citi
Cantor Fitzgerald
Medtronic
Federal Trade Commission
Teva

Generated: October 19, 2017

DrugPatentWatch Database Preview

LARIAM Drug Profile

« Back to Dashboard

What is the patent landscape for Lariam, and when can generic versions of Lariam launch?

Lariam is a drug marketed by Roche and is included in one NDA.

The generic ingredient in LARIAM is mefloquine hydrochloride. There are six drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the mefloquine hydrochloride profile page.

Summary for Tradename: LARIAM

US Patents:0
Applicants:1
NDAs:1
Bulk Api Vendors: see list17
Clinical Trials: see list2
Patent Applications: see list684
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:LARIAM at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Roche
LARIAM
mefloquine hydrochloride
TABLET;ORAL019591-001May 2, 1989DISCNYesNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: LARIAM

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Roche
LARIAM
mefloquine hydrochloride
TABLET;ORAL019591-001May 2, 1989► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Fish and Richardson
Express Scripts
Julphar
Teva
Dow
Farmers Insurance
US Department of Justice
Colorcon
Deloitte
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot